Safety and effectiveness of COVID-19 vaccines during pregnancy is a particular concern
affecting vaccination uptake by this vulnerable group. Here we evaluated evidence from 23 …

Background Gender is emerging as a significant factor in the social, economic, and health
effects of COVID-19. However, most existing studies have focused on its direct impact on …

Background Infants younger than 6 months of age are at high risk for complications of
coronavirus disease 2019 (Covid-19) and are not eligible for vaccination. Transplacental …

Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and
associated mortality than the general population. Owing to this increased risk, patients with …

Importance Pregnant women were excluded from the BNT162b2 messenger RNA (mRNA)
COVID-19 vaccine (Pfizer-BioNTech) preauthorization trial. Therefore, observational data on …

Some reproductive-aged individuals remain unvaccinated against coronavirus disease
2019 (COVID-19) because of concerns about potential adverse effects on fertility. Using data …

Pregnancy is an independent risk factor for severe covid-19. Vaccination is the best way to
reduce the risk for SARS-CoV-2 infection and limit its morbidity and mortality. The current …

Importance There is limited comparative epidemiological evidence on outcomes associated
with COVID-19 vaccination during pregnancy; monitoring pregnancy outcomes in large …

Importance Data about the safety of vaccines against SARS-CoV-2 during pregnancy are
limited. Objective To examine the risk of adverse pregnancy outcomes after vaccination …

Importance The study team previously showed that maternal mRNA COVID-19 vaccination
during pregnancy confers protection against SARS-CoV-2 infection and COVID-19–related …